Colchicine to prevent another stroke after a mild to moderate one
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether the anti-inflammatory drug colchicine can help prevent a second stroke in people who recently had a mild to moderate ischemic stroke. If you had a stroke 1 to 4 weeks ago and are between 18 and 80 years old, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 80 years old
- You had a mild to moderate ischemic stroke (confirmed by CT or MRI) 7 to 30 days ago
- You can take colchicine (no known allergy or intolerance)
- You do not have inflammatory bowel disease, chronic diarrhea, or certain nerve/muscle problems
- Your liver and kidney function are within safe limits
- You are not currently taking certain medications that interact with colchicine
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a drug called colchicine can reduce the risk of future strokes and improve recovery after a recent brain bleed (intracerebral hemorrhage). It is for people who also have heart or blood vessel disease or multiple risk factors like high blood pressure or diabetes.
This Phase 3 study tests whether low-dose colchicine added to ticagrelor (a blood-thinning medicine) helps prevent another ischemic stroke in people whose first stroke was caused by clogged arteries. It aims to lower the risk of repeat stroke after recovery from a recent event.
This Phase 2 trial tests whether colchicine can help people with significant narrowing in brain arteries (from atherosclerosis) after a recent stroke or “mini-stroke.” It aims to reduce the risk related to this condition during the early period after symptoms begin.
This trial is testing whether a combination of two medicines—colchicine (an anti-inflammatory) and a low dose of rivaroxaban (a blood thinner)—can help prevent future heart attacks, strokes, or other blood vessel problems in people who recently had a stroke caused by a blood clot.
This trial tests whether a low dose of the anti-inflammatory drug colchicine can help people who have recently had a heart attack or unstable angina. It aims to see if colchicine reduces the risk of future heart problems.
This trial tests if colchicine can reduce the risk of another stroke caused by bleeding in the brain due to a condition called cerebral amyloid angiopathy (CAA). You may qualify if you've recently had a brain bleed from CAA and have certain signs on brain scans.
Hear when a new Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.